APELLIS Trademark

Trademark Overview

On Friday, September 13, 2019, a trademark application was filed for APELLIS with the United States Patent and Trademark Office. The USPTO has given the APELLIS trademark a serial number of 88616568. The federal status of this trademark filing is REGISTERED as of Tuesday, August 3, 2021. This trademark is owned by Apellis Pharmaceuticals, Inc.. The APELLIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, solely for human use, for the treatment of complement-mediated diseases and disorders
apellis

General Information

Serial Number88616568
Word MarkAPELLIS
Filing DateFriday, September 13, 2019
Status700 - REGISTERED
Status DateTuesday, August 3, 2021
Registration Number6441830
Registration DateTuesday, August 3, 2021
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, December 24, 2019

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of "APELLIS" in stylized letters.
Goods and ServicesPharmaceutical preparations, solely for human use, for the treatment of complement-mediated diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 23, 2019
Primary Code005
First Use Anywhere DateWednesday, March 3, 2021
First Use In Commerce DateWednesday, March 3, 2021

Trademark Owner History

Party NameApellis Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameApellis Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameApellis Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events

Event DateEvent Description
Tuesday, August 3, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, June 29, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, June 28, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, June 19, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 9, 2021USE AMENDMENT FILED
Saturday, June 19, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 9, 2021TEAS STATEMENT OF USE RECEIVED
Friday, February 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 17, 2021EXTENSION 2 GRANTED
Wednesday, February 17, 2021EXTENSION 2 FILED
Wednesday, February 17, 2021TEAS EXTENSION RECEIVED
Tuesday, January 12, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 12, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 12, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, January 12, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 12, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 12, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 14, 2020EXTENSION 1 GRANTED
Friday, August 14, 2020EXTENSION 1 FILED
Friday, August 14, 2020TEAS EXTENSION RECEIVED
Tuesday, February 18, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 24, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 24, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 4, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 18, 2019ASSIGNED TO LIE
Wednesday, November 13, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 13, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, November 13, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 13, 2019EXAMINERS AMENDMENT E-MAILED
Wednesday, November 13, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, November 7, 2019ASSIGNED TO EXAMINER
Monday, September 23, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 17, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

apellis mediated diseases disorders complement treatment preparations solely human pharmaceutical